0
0
11/3/22 at 4:49pm
Organization
News-Medical.Net
47 words
0
Comments
A new study investigated the impact of a monoclonal anti-thymic stromal lymphopoietin (TSLP) antibody on subcutaneous allergen immunotherapy (SCIT) efficacy among patients with allergic rhinitis.
You are the first to view
https://www.news-medical.net/news/20221103/Study-explores-the-potential-use-of-anti-thymic-stromal-lymphopoietin-monoclonal-antibody-as-an-adjuvant-in-allergic-immunotherapy.aspx
Create an account
or login to join the discussion